Systemic treatment for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manushi Aggarwal, Abeer Arain, Zhaohui Jin
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2018
Materias:
Acceso en línea:https://doaj.org/article/dd85b95f2f214bc6854270b02bc26dff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!